Skip to main content
. 2017 Mar 2;2017:1253294. doi: 10.1155/2017/1253294

Figure 3.

Figure 3

(a) Plasma drug level profiles of KS-PEG-WSC NPs and KS-PLGA-TPGS NPs. Each point represents mean of six replicates and each crossbar indicates 1 SEM and (b) change in pharmacokinetic parameters of KS-PEG-WSC NPs relative to KS-PLGA-TPGS NPs.